Levosimendan in Cardiac Failure After Subarachnoid Hemorrhage

Journal of Trauma

Volumn 68, Issue 5, 2010, Pages E108-E110

  Busani, Stefano ^a   Rinaldi, Laura ^a   Severino, Claudia ^a   Cobelli, Milena ^a   Pasetto, Alberto ^a   Girardis, Massimo ^a  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

Cardiogenic; Cerebral aneurysm; Inotropic drugs; Myocardial stunning; Shock; Subarachnoid hemorrhage

Indexed keywords

DOBUTAMINE; DOPAMINE; FENTANYL; INFUSION FLUID; LEVOSIMENDAN; MIDAZOLAM; NORADRENALIN; PROPOFOL;

ADULT; ANISOCORIA; ARTICLE; BRAIN ARTERY ANEURYSM; CARDIOGENIC SHOCK; CASE REPORT; COIL EMBOLIZATION; COMA; COMPUTER ASSISTED TOMOGRAPHY; CONTINUOUS INFUSION; CRANIOTOMY; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ECHOCARDIOGRAPHY; ENDOTRACHEAL INTUBATION; FEMALE; GLASGOW COMA SCALE; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE RELAXATION; HUMAN; HYPERNATREMIA; LUNG ARTERY CATHETER; LUNG GAS EXCHANGE; PERFUSION PRESSURE; POLYURIA; PRIORITY JOURNAL; SEDATION; SINUS TACHYCARDIA; SUBARACHNOID HEMORRHAGE;

EID: 77952254716     PISSN: 00225282     EISSN: None     Source Type: Journal    
DOI: 10.1097/TA.0b013e31817c4284     Document Type: Article

References (15)

1. Cairns CJ, Grant IS. Cardiac and pulmonary complications of subarachnoid haemorrhage: pathophysiology, diagnosis and management. Int J Intensive Care. 2003;10:109-120.
2. Solenski NJ, Haley EC Jr, Kassel NF, et al. Medical complications of aneurysmal subarachnoid hemorrhage: a report on the multicenter, cooperative aneurysm study. Participants of the Multicenter Cooperative Aneurysm Study. Crit Care Med. 1995;23:1007-1017.
3. Banki NM, Kopelnik A, Dae MW, et al. Acute neurocardiogenic injury after subarachnoid hemorrhage. Circulation. 2005;112:3314-3319.
4. Macmillan CS, Grant IS, Andrews PJ. Pulmonary and cardiac sequelae of subarachnoid haemorrhage: time for active management? Intensive Care Med. 2002;28:1012-1023.
5. Parr MJ, Finfer SR, Morgan MK. Reversible cardiogenic shock complicating subarachnoid haemorrhage. BMJ. 1996;313:681-683.
6. Follath F, Cleland JG, Just H, et al. Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure (the LIDO study): a randomised double-blind trial. Lancet. 2002;360:196-202.
7. Moiseyev VS, Poder P, Andrejevs N, et al; RUSSLAN Study Investigators. Safety and efficacy of a novel calcium sensitizer, levosimendan, in patients with left ventricular failure due to an acute myocardial infarction. A randomized, placebo-controlled, double-blind study (RUSSLAN). Eur Heart J. 2002;18:1422-1432.
8. Mebazaa A, Nieminen MS, Packer M, et al; SURVIVE Investigators. Levosimendan vs dobutamine for patients with acute decompensated heart failure: the SURVIVE Randomized Trial. JAMA. 2007;297:1883-1891.
9. Follath F, Franco F, Cardoso JS. European experience on the practical use of levosimendan in patients with acute heart failure syndromes. Am J Cardiol. 2005;96:80G-85G.
10. Archan S, Toller W. Levosimendan: current status and future prospects. Curr Opin Anaesthesiol. 2008;21:78-84.
11. Rivera J, Romero KA, Gonzales-Chon O, Uruchurtu E, Marquez MF, Guevara M. Severe stunned myocardium after lightning strike. Crit Care Med. 2007;35:280-285.
12. Cunha-Goncalves D, Perez-de-Sa V, Dahm P, Grins E, Thorne J, Blomquist S. Cardiovascular effects of levosimendan in the early stages of endotoxemia. Shock. 2007;28:71-77.
13. Zaroff JG, Pawlikowska L, Miss JC, et al. Adrenoceptor polymorphisms and the risk of cardiac injury and dysfunction after subarachnoidal hemorrhage. Stroke. 2006;37:1680-1685.
14. Ellger BM, Zahn PK, Van Aken HK, Schmidt C, Brussel T. Levosimendan: a promising treatment for myocardial stunning? Anaesthesia. 2006;61:61-63.
15. Figgitt DP, Gillies PS, Goa KL. Levosimendan. Drugs. 2001;61:613-627; discussion 628-629.